Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Blog Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…CertaraJanuary 16, 2026
CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access Webinar CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access CertaraJanuary 14, 2026
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development Publication Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of…CertaraJanuary 7, 2026
Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions Blog Delivering on Deadline: Why Pharmacometrics (PMx) Is the Anchor of Successful Regulatory Submissions Explore how PMx regulatory submissions, exposure-response modeling, and strategic pharmacometrics planning support successful and timely…CertaraDecember 29, 2025
Strategic Project Management for Accelerated Drug Development Fact Sheet Strategic Project Management for Accelerated Drug Development Expert project leadership to keep complex programs on track, aligned, and moving forward—so you can…CertaraDecember 23, 2025
Pharma positions itself for 2026 amid an evolving US landscape Press Coverage Pharma positions itself for 2026 amid an evolving US landscape Explore how U.S. policy changes — including tariffs, onshoring, and Most Favored Nation pricing —…CertaraDecember 22, 2025
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection Publication A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection This study synthesizes data from a large body of clinical trials to evaluate rates of…CertaraDecember 18, 2025
Accelerated ADC Approval Through Expert Modeling and Data Rescue Case Study Accelerated ADC Approval Through Expert Modeling and Data Rescue See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…CertaraDecember 15, 2025
Merck Advances Pediatric Oncology with Innovative ADC Modeling Case Study Merck Advances Pediatric Oncology with Innovative ADC Modeling Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…CertaraDecember 12, 2025